Form 1-A/A — Fisher Wallace Laboratories, Inc.
0001104659-23-019377 · filed Feb 13, 2023
https://fisherwallace.com
(possible website — auto-inferred, not verified)
Offering
- Total offering
- —
- Total sold
- —
- Security type
- —
- Price per security
- $10.6700
- Over-allotment
- —
- Jurisdictions
- —
Issuer
- CIK
- 1787792
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 630 FLUSHING AVENUE, BOX 104
BROOKLYN, OH 11206
Most recent fiscal year financials
Financial statement requirements vary by tier and report. Verify the audit or review status in the original SEC filing.
- Total assets
- $1,999,403
- Total liabilities
- $1,542,723
- Cash
- —
- Total revenues
- $4,230,290
- Net income
- $3,606,587
Same issuer's Form D filings
-
D · Jun 13, 2025$5M
Same issuer's Reg CF (Form C) raises
- Form C · Oct 7, 2026 · via DEALMAKER SECURITIES LLC $3.9M
- Form C-U · Oct 6, 2026 · via DEALMAKER SECURITIES LLC $4.4M
- Form C-U · Sep 21, 2026 · via DEALMAKER SECURITIES LLC $4.4M
- Form C/A · Jul 16, 2026 · via DEALMAKER SECURITIES LLC $4.4M
- Form C/A · May 22, 2026 · via DEALMAKER SECURITIES LLC $4.4M
View the original filing on SEC EDGAR ↗